Abstract:The goal of this study was to determine whether ultrasound mediated microbubbles destruction (UMMD) could inhibit colon cancer growth in a mouse model. Six-week-old balb/c female nude mice were subcutaneously inoculated with HT29-GFP cells (HT29 cells labeled with green fluorescent dye) in axilla to establish a xenograft mouse model of colon carcinoma, which were randomly divided into five groups (n=10 each): group A (blank group): no treatment; group B (saline only); group C (saline+ultrasound exposure); group D (intravenous microbubbles only); and group E (intravenous microbubbles+ultrasound exposure). Treatment of each group was performed on days 20, 21, and 22 after inoculation. Tumor growth and metastatic spread were monitored by the whole-body fluorescent imaging, tumor volume growth and body weight growth curve were obtained as well. The mice were euthanized 30 days after treatment. Specimens of the tumor tissues were evaluated pathologically using light microscopy and transmission electron microscopy. Necrosis percentages, microvascular density and tumor cells damage of each tumor were assessed histologically. Our data indicate that: (1) tumor growth in group E (intravenous microbubbles+ultrasound exposure) was significantly decreased after four weeks post inoculation, compared with other control treatments (P<0.05); (2) the tumor weight at sacrifice in group E was significantly lower than that in other groups; (3) The intravenous microbubbles combined with ultrasound exposure treated mice showed significantly decreased expression levels of CD31. (4)The pathological changes of absence of nucleus membrane, chromatin condensation, mitochondrial vacuolation and hemorrhagic damage of microvessel were observed in the tumors of group E only, whereas these changes occurred rarely in other groups; and (5) no metastatic lesion was found in any group throughout this study using whole-body fluorescent imaging, and the skin of the mouse in group E was intact after UMMD treatment. Our results suggest that UMMD can be used as a promising novel therapeutic strategy to treat colon cancer.

High-Efficacy Targeting of Colon-Cancer Liver Metastasis with Salmonella Typhimurium A1-R Via Intra-Portal-Vein Injection in Orthotopic Nude-Mouse Models

Therapeutic Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Human Colorectal Cancer Liver Metastasis in Orthotopic Nude-Mouse Models.

Tumor-Targeting Salmonella Typhimurium A1-R Efficacy On Colon Cancer Liver Metastasis Alone And In Combination With Fluorescence-Guided Surgery

Adjuvant Treatment with Tumor-Targeting Salmonella Typhimurium A1-R Reduces Recurrence and Increases Survival after Liver Metastasis Resection in an Orthotopic Nude Mouse Model

A novel therapeutic strategy using ultrasound mediated microbubbles destruction to treat colon cancer in a mouse model.

Determination of the Optimal Route of Administration of Salmonella Typhimurium A1-R to Target Breast Cancer in Nude Mice

Abstract 583: Treatment of human liver cancer in nude mice with a tumor-targeting<i>Salmonella typhimurium</i>auxotroph

Toxicology and Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R Compared to VNP 20009 in a Syngeneic Mouse Tumor Model in Immunocompetent Mice

Intraperitoneal Administration of Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Disseminated Human Ovarian Cancer and Extends Survival in Nude Mice

Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Anti-Angiogenesis Therapy on A Pancreatic Cancer Patient-Derived Orthotopic Xenograft (pdox) and Cell-Line Mouse Models

Efficacy Against Lung Metastasis with a Tumor-Targeting Mutant of Salmonella Typhimurium in Immunocompetent Mice.

Efficacy of tumor-targeting Salmonella typhimurium A1-R on nude mouse models of metastatic and disseminated human ovarian cancer.

Abstract 2802: Salmonella typhimurium A1-R inhibits brain metastasis in an orthotropic breast cancer nude-mouse model.

Inhibition of Spontaneous and Experimental Lung Metastasis of Soft-Tissue Sarcoma by Tumor-Targeting Salmonella Typhimurium A1-R

Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Peritoneal Dissemination Of Ovarian Cancer And Prolongs Survival Of The Tumor-Bearing Nude Mice

Tumor-Targeting Salmonella Typhimurium A1-R Promotes Cd8+T Cell Infiltration In Pancreatic Cancer In An Orthotopic Syngeneic Mouse Model

Comparison of the Selective Targeting Efficacy Ofsalmonella Typhimuriuma1-R and VNP20009 on the Lewis Lung Carcinoma in Nude Mice

Tumor-targeting Salmonella Typhimurium A1-R Prevents Experimental Human Breast Cancer Bone Metastasis in Nude Mice

Tumor‐Targeting Salmonella Typhimurium A1‐R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic‐Cancer Orthotopic Mouse Model

Tumor-Targeting Salmonella Typhimurium A1-R Arrests Growth Of Breast-Cancer Brain Metastasis

Efficacy Of Tumor-Targeting Salmonella Typhimurium A1-R On Highly Metastatic Human Pancreatic Cancer In Nude Mice